Clinical trial
The Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation of Nerve Autografts After Severe Peripheral Nerve Injury (PNI)
NCT03999424 is registered in ClinicalTrials.gov with W. Dalton Dietrich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation of Nerve Autografts After Severe Peripheral Nerve Injury (PNI)
- Lead sponsor
- W. Dalton Dietrich
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 24, 2019
- Completion date
- December 4, 2025
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.